A second unrelated bone marrow transplant with an unrelated donor marrow: treatment of a patient with relapsed leukemia.
A second bone marrow transplant might be considered as an option in patients with leukemia relapsing after bone marrow transplantation. We report the successful treatment of a patient with relapsed ALL with a second BMT from the same unrelated donor. We evaluated the usefulness of an unrelated donor as the source of the second BMT in this clinical setting. The conditioning regimen for the first transplantation consisted of BU and CY while fractionated TBI and CY were used for the second BMT. Acute skin GVHD, grade III which developed after second BMT, was successfully treated with the use of a new immunosuppressive drug, mycophenolate mofetil. Hemorrhagic cystitis and a CMV infection developed as complications during the second BMT and were successfully treated. The patient was alive and well after the second BMT with limited chronic skin GVHD up to day +170.
Basara
N
N
Clinic of Bone Marrow Transplantation and Hematology/Oncology, Idar Oberstein, Germany.
Bischoff
M
M
Blau
I W
IW
Hermann
D
D
Römer
E
E
Rudolphi
M
M
Kirsten
D
D
Sanchez
H
H
Fauser
A A
AA
D000328:Adult; D016026:Bone Marrow Transplantation; D006650:Histocompatibility Testing; D006801:Humans; D008297:Male; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000628:therapy*; D012008:Recurrence; D012086:Reoperation